{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"82.3","upperLimit":"94.6","value":"88.5"},{"groupId":"OG001","lowerLimit":"89.7","upperLimit":"98.7","value":"94.2"}]}]}],"denomUnitsSelected":"Sentinel lymph nodes (SLNs)","denoms":[{"counts":[{"groupId":"OG000","value":"50"},{"groupId":"OG001","value":"50"}],"units":"Participants"},{"counts":[{"groupId":"OG000","value":"104"},{"groupId":"OG001","value":"104"}],"units":"Sentinel lymph nodes (SLNs)"}],"description":"Relative node detection sensitivity (S) was defined as the proportion of sentinel lymph nodes (SLNs) that were identified with each instrument, with the proportion determined as the number of true positives (TP) divided by the total evaluated (N). The outcome result is expressed as the percentage for each device with 95% confidence intervals.","dispersionType":"95% Confidence Interval","groups":[{"description":"The prototype intraoperative handheld gamma camera (pIHGC)\n\nradioactive Tc99M: Lymphoscintigraphy involves injection of 0.4 to 1.0 mCi of radioactive Tc99M sulfur colloid around at the tumor site.","id":"OG000","title":"Intraoperative Handheld Gamma Camera (pIHGC)"},{"description":"Lymphoscintigraphy with standard of care intraoperative gamma probes (GP)\n\nradioactive Tc99M: Lymphoscintigraphy involves injection of 0.4 to 1.0 mCi of radioactive Tc99M sulfur colloid around at the tumor site.","id":"OG001","title":"Gamma Probes (GP)"}],"paramType":"NUMBER","populationDescription":"Sentinel lymph nodes (SLNs) were evaluated for detection by the 2 methods.","reportingStatus":"POSTED","timeFrame":"1 day","title":"Relative Node Detection Sensitivity","type":"PRIMARY","typeUnitsAnalyzed":"Sentinel lymph nodes (SLNs)","unitOfMeasure":"Percentage (%) of SLNs detected"}